Compare · ALGN vs APEN
ALGN vs APEN
Side-by-side comparison of Align Technology Inc. (ALGN) and Apollo Endosurgery Inc. (APEN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALGN and APEN operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ALGN is the larger of the two at $12.01B, about 59.8x APEN ($201.0M).
- ALGN has hit the wire 16 times in the past 4 weeks while APEN has been quiet.
- ALGN has more recent analyst coverage (25 ratings vs 6 for APEN).
- Company
- Align Technology Inc.
- Apollo Endosurgery Inc.
- Price
- $167.69-0.36%
- $9.99+0.71%
- Market cap
- $12.01B
- $201.0M
- 1M return
- -3.59%
- -
- 1Y return
- -7.34%
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2001
- News (4w)
- 16
- 0
- Recent ratings
- 25
- 6
Align Technology Inc.
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Apollo Endosurgery Inc.
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to place full thickness sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands; and Orbera Coach, a digital and remotely delivered aftercare program. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Brazil, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.
Latest ALGN
- Align Technology Awards Funding to Universities Worldwide for Advancing Orthodontic and Dental Research
- SEC Form SD filed by Align Technology Inc.
- Director Vitalone Britt J. converted options into 1,443 shares (SEC Form 4)
- Director Siegel Susan E converted options into 1,745 shares, increasing direct ownership by 19% to 10,723 units (SEC Form 4)
- Director Saia Andrea Lynn converted options into 1,745 shares, increasing direct ownership by 11% to 17,318 units (SEC Form 4)
- Director Poul Mojdeh converted options into 1,745 shares, increasing direct ownership by 97% to 3,553 units (SEC Form 4)
- Director Myong Anne converted options into 1,745 shares, increasing direct ownership by 22% to 9,830 units (SEC Form 4)
- Director Larkin C Raymond Jr converted options into 2,326 shares, increasing direct ownership by 9% to 27,454 units (SEC Form 4)
- Director Dallas Kevin J converted options into 1,745 shares, increasing direct ownership by 12% to 16,168 units (SEC Form 4)
- Director Lacob Joseph converted options into 1,745 shares (SEC Form 4)
Latest APEN
- SEC Form SC 13G/A filed by Apollo Endosurgery Inc. (Amendment)
- SEC Form 15-12G filed by Apollo Endosurgery Inc.
- SEC Form EFFECT filed by Apollo Endosurgery Inc.
- SEC Form EFFECT filed by Apollo Endosurgery Inc.
- SEC Form EFFECT filed by Apollo Endosurgery Inc.
- SEC Form EFFECT filed by Apollo Endosurgery Inc.
- SEC Form EFFECT filed by Apollo Endosurgery Inc.
- SEC Form EFFECT filed by Apollo Endosurgery Inc.
- SEC Form EFFECT filed by Apollo Endosurgery Inc.
- SEC Form EFFECT filed by Apollo Endosurgery Inc.